Beyond Chemistry: Investigating the Physical, Pharmacological, and Computational Aspects of Polyoxometalate Integrated Solid Lipid Nanoparticles for Cancer Treatment
Rattachement africain : pk, sa, ie, ae. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Purpose: The solid lipid nanoparticles of transitional metal complexes (POMs) were prepared with natural lipids with the aim of developing a safer therapeutic approach for cancer treatment. Methods: Natural lipids were used to create solid lipid nanoparticles containing transitional metal complexes (POMs). Results: The nanoparticles had displayed appreciable entrapment and loading percentage of P 5 W 30 . The zeta capacitance was measured to be − 32.57± 6.44 mV with average particle dimension of 160.5± 8.61 nm and polydispersity index (PDI) of around 0.3814± 0.096. The effectiveness of P 5 W 30 -BW-SLNs in inhibiting the growth of HeLa cells was found to be higher (IC 50 = 3.02± 2.14 μg/mL) compared to pure P 5 W 30 (IC 50 = 7.93± 5.08 μg/mL). Further examinations of DNA damage were made through comet test and flow cytometry techniques. The assessment of tumor regression and survival was conducted, and comparison was recorded. The P 5 W 30 -BW-SLNs resulted in a 72.91% increase in survival rates and a reduction in tumor burden by 2.967± 0.543%. Moreover, the computational findings demonstrate a strong connection with the actual data, providing a plausible explanation for the notable chemopreventive efficacy of POM against HeLa cell lines. Conclusion: The study’s findings might pave the way for a more efficient delivery system in cancer treatment. Keywords: polyoxometalate, beeswax, nanoparticle, molecular docking
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Beyond Chemistry: Investigating the Physical, Pharmacological, and Computational Aspects of Polyoxometalate Integrated Solid Lipid Nanoparticles for Cancer Treatment
- Date Crossref
- 01/01/2025
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.